Novel hematological therapies were the main focus of the EHA congress
Several new agents and combination therapies for the treatments of haematological malignant and non-malignant diseases were presented at the 24th congress of the European Haematology Association (EHA) that took place 13-16 June 2019 in Amsterdam [more]